HEALTH● LOW5d ago · Oct 8, 2026, 2:30 PM
A rare healthcare issue both parties agree on: A solution to Alzheimer’s that can’t wait
The Hill · north america
Bipartisan legislators introduced the ASAP Act to authorize Medicare coverage for FDA-approved blood-based biomarker tests aimed at the early detection of Alzheimer's and other dementias.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH56m agoAt NIFST AGM: NAFDAC DG charges food scientists on food safety, qualityVanguard NigeriaHEALTH1h agoAMR: FG warns of growing threat of drug-resistant infectionsVanguard NigeriaHEALTH1h agoUttar Pradesh MBBS doctors protest over pay disparity, pending salary arrears; announce work boycottThe HinduHEALTH1h agoDoctors discuss Pope Leo's lung cancer diagnosisCBS News